Halberd

Halberd Accounts Payable

The Accounts Payable of Halberd (HALB) as of Oct 11, 2026 is 571,862.00 USD. In the previous year, Accounts Payable was 390,392.00 USD — a change of 46.48% (higher).

Accounts Payable

571,862.00USD

YoY

46.48%

Last updated:

Accounts Payable of Halberd is 2025 571,862.00 USD. Accounts Payable of Halberd was 2024 390,392.00 USD. It decreases by 46.48% higher compared to the previous year.

The Halberd Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2016
401,012.00 USD
Jan 1, 2017
417,374.00 USD
Jan 1, 2020
7,947.00 USD
Jan 1, 2021
177,010.00 USD
Jan 1, 2022
376,839.00 USD
Jan 1, 2023
581,818.00 USD
Jan 1, 2024
390,392.00 USD
Jan 1, 2025
571,862.00 USD
The Halberd Accounts Payable history
YEARAccounts PayableYoY
571,862.00USD+46.48%
390,392.00USD-32.90%
581,818.00USD+54.39%
376,839.00USD+112.89%
177,010.00USD+2,127.38%
7,947.00USD-98.10%
417,374.00USD+4.08%
401,012.00USD—
Access this data via the Eulerpool API

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

Accounts Payable of Halberd is 571,862.00 USD in 2025.

Accounts Payable of Halberd changed from 390,392.00 USD to 571,862.00 USD, representing a 46.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Halberd since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Halberd historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Halberd

All Key Metrics — Halberd